🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Neil Vasan

Columbia University Irving Medical Center

ORCID: 0000-0003-1779-484X

Also affiliated with NYU Langone Health, New York University

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from Genetic Heterogeneity and Tissue-specific Patterns of Tumors with Multiple PIK3CA Mutations

(2023)10.1158/1078-0432.c.6533080.v1
Top 100%
0DataRank
Top 100%0 citations

Dexter X. Jin, Ruchita Rathod, Jeffrey S. Ross, Lewis C. Cantley, Maurizio Scaltriti +6 more

Papers

Driven by 14 papers — median percentile 0. Top paper: “Metastasis and Immune Evasion from Extracellular cGAMP Hydrolysis”.

Metastasis and Immune Evasion from Extracellular cGAMP Hydrolysis

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0387
N/A
6.9DataRank · unranked
289 citations

Mercedes A. Duran Paez, Ninjit Dhanota, Walid K. Chatila, Sarah E. Bettigole, John Y. H. Kwon +36 more

The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity

Cancer Cell(2023)10.1016/j.ccell.2023.05.014
N/A
1.8DataRank · unranked
96 citations

Johannes C. Melms, Meri Rogava, Chris J. Frangieh, Joanna Poźniak, Shivem B. Shah +28 more

Mapping variant effects on anti-tumor hallmarks of primary human T cells with base-editing screens

Nature Biotechnology(2024)10.1038/s41587-024-02235-x
N/A
0.896DataRank · unranked
36 citations

Parin Shah, Neeharika Kothapalli, Shivem B. Shah, Gergő Nikolényi, D. Zack Brodtman +12 more

Phase and context shape the function of composite oncogenic mutations

Nature(2020)10.1038/s41586-020-2315-8
N/A
0.581DataRank · unranked
47 citations

Francisco J. Sánchez‐Rivera, Yanyan Cai, Craig M. Bielski, Evan Biederstedt, Philip Jonsson +13 more

The CD58:CD2 axis is co-regulated with PD-L1 via CMTM6 and governs anti-tumor immunity

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.21.485049
N/A
0.360DataRank · unranked
10 citations

Johannes C. Melms, Meri Rogava, Chris J. Frangieh, Shivem B. Shah, Zachary Walsh +21 more

Epinephrine inhibits PI3Kα via the Hippo kinases

Cell Reports(2023)10.1016/j.celrep.2023.113535
N/A
0DataRank · unranked
4 citations

Shakti Ramsamooj, Tiffany Perrier, Katarina Liberatore, Louise Lantier, Neil Vasan +19 more

Data from Genetic Heterogeneity and Tissue-specific Patterns of Tumors with Multiple PIK3CA Mutations

(2023)10.1158/1078-0432.c.6533080.v1
Top 100%
0DataRank
Top 100%0 citations

Dexter X. Jin, Ruchita Rathod, Jeffrey S. Ross, Lewis C. Cantley, Maurizio Scaltriti +6 more

Therapeutic potential of inhibiting the PI3Kγ complex for leukemia

Cell chemical biology(2024)10.1016/j.chembiol.2024.06.009
N/A
0DataRank · unranked
2 citations

Neil Vasan, Hanna Karvonen

LIN28B-mediated PI3K/AKT pathway activation promotes metastasis in colorectal cancer models

Journal of Clinical Investigation(2025)10.1172/jci186035
N/A
0DataRank · unranked
16 citations

Kensuke Sugiura, Secunda W. Kariuki, David Cohen, Samuel Flashner, Andres J. Klein–Szanto +8 more

Clinicogenomic landscape and function of PIK3CA , AKT1 , and PTEN mutations in breast cancer

medRxiv(2025)10.1101/2025.06.18.25329632
N/A
0DataRank · unranked
0 citations

Saumya D. Sisoudiya, Hanna Tukachinsky, Alexa B. Schrock, Smruthy Sivakumar, Ethan S. Sokol +2 more

TRK xDFG Mutations Trigger a Sensitivity Switch from Type I to II Kinase Inhibitors

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0571
N/A
0DataRank · unranked
70 citations

Ji Eun Lee, Srinivasaraghavan Kannan, Alison M. Schram, Helen Won, Sophie Shifman +29 more

Treating Alpelisib-Induced Hyperglycemia with Very Low Carbohydrate Diets and Sodium-Glucose Co-Transporter 2 Inhibitors: A Case Series

Integrative Cancer Therapies(2021)10.1177/15347354211032283
N/A
0DataRank · unranked
23 citations

Parker N. Hyde, John N. Falcone, Aaron Neinstein, Neil Vasan, Ritika Chitkara +7 more

Genetic Heterogeneity and Tissue-specific Patterns of Tumors with Multiple PIK3CA Mutations

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-2270
N/A
0DataRank · unranked
30 citations

Dexter X. Jin, Ruchita Rathod, Jeffrey S. Ross, Lewis C. Cantley, Maurizio Scaltriti +6 more

A New Wave of PI3Kα Inhibitors

Cancer Discovery(2023)10.1158/2159-8290.cd-23-0945
N/A
0DataRank · unranked
10 citations

Neil Vasan, Alison L. Kearney